Acadia Healthcare Company, Inc. (ACHC) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-04-29

Key Insights

Acadia reported Q1 2026 results on April 29, 2026, with earnings and operational metrics disclosed through press release and investor conference call scheduled for April 30, 2026, indicating routine quarterly earnings announcement.
The company faces significant regulatory headwinds from the One Big Beautiful Bill Act (OBBBA) enacted July 4, 2025, which introduces work/community engagement requirements for Medicaid expansion patients and changes Medicaid financing mechanisms, creating material risk to future payment volumes and revenue.
Forward-looking statement risks highlight integration challenges from acquisitions, potential operational disruptions, cybersecurity threats, and labor/supply chain cost pressures that could materially impact future financial performance and cash flow generation.

Want the newest filings?

This analysis covers the filing from 2026-04-29. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-01-23

Acadia Healthcare's CEO Christopher H. Hunter has departed the company, effective January 20, 2026.
Mr. Hunter will receive separation benefits including a cash severance payment, continued health insurance coverage, and a prorated portion of his outstanding performance-based restricted stock units.
The separation agreement includes a release of claims in favor of Acadia and restrictive covenants for Mr. Hunter.

Filed: 2026-01-20

Acadia Healthcare Company announced the departure of its Chief Executive Officer, Christopher H. Hunter, effective January 20, 2026.
The Board appointed Debra K. Osteen as the new Chief Executive Officer, effective the same date. Osteen previously served as CEO from 2018 to 2022.
Osteen's employment agreement includes a base salary of $1,061,000, an annual cash bonus target of 125% of base salary, and an initial equity award of stock options.

Filed: 2026-01-13

Acadia Healthcare is reaffirming its 2025 financial guidance, providing investors with confidence in the company's performance expectations.
The company is discussing information on slides during its presentation at the 44th Annual J.P. Morgan Healthcare Conference, which could provide insight into its strategic priorities and outlook.
Potential risks identified include difficulties in integrating acquired facilities, reductions in government and commercial payor payments, and disruptions to the company's information technology systems.

Other reports for Acadia Healthcare Company, Inc.

Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.